Consumer Defensive
Live Price
Offline$11.20
+0.00% today
1Y Change
+4.57%
Window
Jun 25, 2025 โ Jun 24, 2026
Coverage: 251 bars ยท Jun 25, 2025 โ Jun 24, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Meiji Holdings Co., Ltd. (MEJHY) is a Consumer Defensive stock with a market cap of $1.01T and listed on OTC. The stock last traded around $11.20 and up 4.6% across the available one-year price window (Jun 25, 2025 โ Jun 24, 2026). Baseline metrics include revenue growth of +4.4%, EPS growth of +2.4%, a dividend yield of 2.8%. What stands out right now is revenue +4.4%, EPS +2.4%, free cash flow -77.3% with operating margin 7.6% and ROIC 5.4%. The dividend matters to the case here, with a current yield around 2.8%. Valuation is more restrained than many high-expectation growth names at P/E 21.9 and price/sales 0.9. Stock Foundry combines MEJHY price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Defensive peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+4.4% vs +1.7% peer median
Operating Margin
Near sector median
+7.6% vs +6.6% peer median
P/E
Above sector median
21.9 vs 14.0 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 7, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +4.4% and EPS at +2.4%, with operating margin around 7.6%.
Shareholder return is still part of the story
The stock is still offering a dividend yield around 2.8%, which matters if the thesis depends on income as much as growth.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +1.4% over the next 5 trading days and finished higher after 2 of those reports.
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 7, 2026 | โ | +0.0% | +0.0% | -4.0% |
2026 Feb 9, 2026 | โ | +2.6% | +2.6% | -0.7% |
2025 Nov 10, 2025 | โ | +4.4% | +1.6% | -6.2% |
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
MEJHY
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
MEJHY Max Drawdown
-28.47%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Uses the longest available daily history for MEJHY and SPY.

Company Overview
Meiji Holdings Co., Ltd.
Other OTC
Meiji Holdings Co., Ltd., through its subsidiaries, manufactures and sells dairy products, confectioneries, nutritional products, and pharmaceuticals in Japan and internationally. The company operates through two segments, Food and Pharmaceutical. It provides yogurt, cheese, drinking milk, beverages, butter and margarine, cream, ice cream, ready meals, chocolates, gummy products, chewing gums, sports nutrition products, infant formula, liquid diet, beauty supplements, OTC medicines, feed stuffs, corn sweeteners, and sugar, as well as transportation and distribution services. The company also offers drugs for infectious diseases and central nervous system disorders, as well as generic drugs; agricultural and livestock chemicals; human and animal vaccines, and blood plasma products; and veterinary drugs for livestock and fisheries comprising antimicrobial injection, disinfectants, oral administration, insecticides, anthelmintic, antipyretic, analgesic, anti-inflammatory, hemostatic, and breeding agents. In addition, it provides insecticides, metabolites, feed additives, and mixed feed; and companion animals, including anesthetics and painkillers, anti-parasitic and gastrointestinal drugs, anti-bacterial agents, antiplasmin agents, vitamin E preparations, and dietary supplements. Meiji Holdings Co., Ltd. was founded in 1916 and is headquartered in Tokyo, Japan.
Valuation, growth, profitability, and balance sheet signals.
Company announcements and filings-style updates.
Next Step
After the overview, the strongest next step is usually chart context or a tighter compare set.